Cargando…

A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth

Resveratrol (RSV) is a natural compound that displays several pharmacological properties, including anti-cancer actions. However, its clinical application is limited because of its low solubility and bioavailability. Here, the antiproliferative and anti-inflammatory activity of a series of phenylace...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimento, Adele, Santarsiero, Anna, Iacopetta, Domenico, Ceramella, Jessica, De Luca, Arianna, Infantino, Vittoria, Parisi, Ortensia Ilaria, Avena, Paola, Bonomo, Maria Grazia, Saturnino, Carmela, Sinicropi, Maria Stefania, Pezzi, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157022/
https://www.ncbi.nlm.nih.gov/pubmed/34067547
http://dx.doi.org/10.3390/ijms22105255
_version_ 1783699586232090624
author Chimento, Adele
Santarsiero, Anna
Iacopetta, Domenico
Ceramella, Jessica
De Luca, Arianna
Infantino, Vittoria
Parisi, Ortensia Ilaria
Avena, Paola
Bonomo, Maria Grazia
Saturnino, Carmela
Sinicropi, Maria Stefania
Pezzi, Vincenzo
author_facet Chimento, Adele
Santarsiero, Anna
Iacopetta, Domenico
Ceramella, Jessica
De Luca, Arianna
Infantino, Vittoria
Parisi, Ortensia Ilaria
Avena, Paola
Bonomo, Maria Grazia
Saturnino, Carmela
Sinicropi, Maria Stefania
Pezzi, Vincenzo
author_sort Chimento, Adele
collection PubMed
description Resveratrol (RSV) is a natural compound that displays several pharmacological properties, including anti-cancer actions. However, its clinical application is limited because of its low solubility and bioavailability. Here, the antiproliferative and anti-inflammatory activity of a series of phenylacetamide RSV derivatives has been evaluated in several cancer cell lines. These derivatives contain a monosubstituted aromatic ring that could mimic the RSV phenolic nucleus and a longer flexible chain that could confer a better stability and bioavailability than RSV. Using MTT assay, we demonstrated that most derivatives exerted antiproliferative effects in almost all of the cancer cell lines tested. Among them, derivative 2, that showed greater bioavailability than RSV, was the most active, particularly against estrogen receptor positive (ER+) MCF7 and estrogen receptor negative (ER-) MDA-MB231 breast cancer cell lines. Moreover, we demonstrated that these derivatives, particularly derivative 2, were able to inhibit NO and ROS synthesis and PGE2 secretion in lipopolysaccharide (LPS)-activated U937 human monocytic cells (derived from a histiocytoma). In order to define the molecular mechanisms underlying the antiproliferative effects of derivative 2, we found that it determined cell cycle arrest at the G1 phase, modified the expression of cell cycle regulatory proteins, and ultimately triggered apoptotic cell death in both breast cancer cell lines. Taken together, these results highlight the studied RSV derivatives, particularly derivative 2, as promising tools for the development of new and more bioavailable derivatives useful in the treatment of breast cancer.
format Online
Article
Text
id pubmed-8157022
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81570222021-05-28 A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth Chimento, Adele Santarsiero, Anna Iacopetta, Domenico Ceramella, Jessica De Luca, Arianna Infantino, Vittoria Parisi, Ortensia Ilaria Avena, Paola Bonomo, Maria Grazia Saturnino, Carmela Sinicropi, Maria Stefania Pezzi, Vincenzo Int J Mol Sci Article Resveratrol (RSV) is a natural compound that displays several pharmacological properties, including anti-cancer actions. However, its clinical application is limited because of its low solubility and bioavailability. Here, the antiproliferative and anti-inflammatory activity of a series of phenylacetamide RSV derivatives has been evaluated in several cancer cell lines. These derivatives contain a monosubstituted aromatic ring that could mimic the RSV phenolic nucleus and a longer flexible chain that could confer a better stability and bioavailability than RSV. Using MTT assay, we demonstrated that most derivatives exerted antiproliferative effects in almost all of the cancer cell lines tested. Among them, derivative 2, that showed greater bioavailability than RSV, was the most active, particularly against estrogen receptor positive (ER+) MCF7 and estrogen receptor negative (ER-) MDA-MB231 breast cancer cell lines. Moreover, we demonstrated that these derivatives, particularly derivative 2, were able to inhibit NO and ROS synthesis and PGE2 secretion in lipopolysaccharide (LPS)-activated U937 human monocytic cells (derived from a histiocytoma). In order to define the molecular mechanisms underlying the antiproliferative effects of derivative 2, we found that it determined cell cycle arrest at the G1 phase, modified the expression of cell cycle regulatory proteins, and ultimately triggered apoptotic cell death in both breast cancer cell lines. Taken together, these results highlight the studied RSV derivatives, particularly derivative 2, as promising tools for the development of new and more bioavailable derivatives useful in the treatment of breast cancer. MDPI 2021-05-17 /pmc/articles/PMC8157022/ /pubmed/34067547 http://dx.doi.org/10.3390/ijms22105255 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chimento, Adele
Santarsiero, Anna
Iacopetta, Domenico
Ceramella, Jessica
De Luca, Arianna
Infantino, Vittoria
Parisi, Ortensia Ilaria
Avena, Paola
Bonomo, Maria Grazia
Saturnino, Carmela
Sinicropi, Maria Stefania
Pezzi, Vincenzo
A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title_full A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title_fullStr A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title_full_unstemmed A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title_short A Phenylacetamide Resveratrol Derivative Exerts Inhibitory Effects on Breast Cancer Cell Growth
title_sort phenylacetamide resveratrol derivative exerts inhibitory effects on breast cancer cell growth
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157022/
https://www.ncbi.nlm.nih.gov/pubmed/34067547
http://dx.doi.org/10.3390/ijms22105255
work_keys_str_mv AT chimentoadele aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT santarsieroanna aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT iacopettadomenico aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT ceramellajessica aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT delucaarianna aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT infantinovittoria aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT parisiortensiailaria aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT avenapaola aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT bonomomariagrazia aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT saturninocarmela aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT sinicropimariastefania aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT pezzivincenzo aphenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT chimentoadele phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT santarsieroanna phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT iacopettadomenico phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT ceramellajessica phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT delucaarianna phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT infantinovittoria phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT parisiortensiailaria phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT avenapaola phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT bonomomariagrazia phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT saturninocarmela phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT sinicropimariastefania phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth
AT pezzivincenzo phenylacetamideresveratrolderivativeexertsinhibitoryeffectsonbreastcancercellgrowth